Register entry
Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Registered sites
- 0
- Drug products
- 10
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
10Showing 10 of 10.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| E.E.S | Erythromycin Ethylsuccinate | GRANULE, FOR SUSPENSION | NDA |
| E.E.S | Erythromycin Ethylsuccinate | GRANULE, FOR SUSPENSION | NDA |
| E.E.S 400 | Erythromycin Ethylsuccinate | TABLET | ANDA |
| ERYTHROMYCIN ETHYLSUCCINATE | Erythromycin Ethylsuccinate | TABLET | ANDA |
| Edarbyclor | Azilsartan kamedoxomil and chlorthalidone | TABLET | NDA |
| Edarbyclor | Azilsartan kamedoxomil and chlorthalidone | TABLET | NDA |
| Ery-Ped | Erythromycin Ethylsuccinate | SUSPENSION | NDA |
| Ery-Ped | Erythromycin Ethylsuccinate | SUSPENSION | NDA |
| Horizant | gabapentin enacarbil | TABLET, EXTENDED RELEASE | NDA |
| Horizant | gabapentin enacarbil | TABLET, EXTENDED RELEASE | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.